GFAP and early-onset autosomal dominant Alzheimer disease: To investigate the role of NOX4 in Alzheimer’s disease, we conducted immunofluorescence staining to measure the levels of NOX4 protein in GFAP-positive astrocytes in the cortical region of APP/PS1 transgenic mice and wild-type (WT) mice.